Literature DB >> 21908023

In vitro colonization of human spermatogonia stem cells: effect of patient's clinical characteristics and testicular histologic findings.

Mohammad Reza Nowroozi1, Hamed Ahmadi, Shahram Rafiian, Tooba Mirzapour, Mansoureh Movahedin.   

Abstract

OBJECTIVE: To evaluate the effect of the demographic/clinical characteristics of patients and testicular histologic findings on the in vitro colonization of human spermatogonial stem cells (SSCs). In vitro isolation and proliferation of human SSCs has emerged as a suitable method for the enrichment of spermatogonia germ cells.
METHODS: SSCs were isolated from the testicular biopsies of 47 infertile men with nonobstructive azoospermia and co-cultured with a Sertoli cell monolayer. Age, infertility duration, medical/surgical history, testicular size, and testicular histologic findings were recorded. The patients were divided into 2 groups according to the growth/no growth of human SSC colonies in culture. As the main outcome measure, the number and diameter of germ cell-derived colonies were compared between 2 groups in days 8, 13, and 18 after cultivation with respect to the recorded parameters.
RESULTS: No difference was found between the 2 groups regarding the demographic/clinical parameters. Maturation arrest at the premeiotic spermatogonia stage was present in a considerably greater proportion in the group with growth of human SSC colonies compared with the group without growth of human SSC colonies (14 [45.1%] of 31 versus 3 [18.7%] of 16; P < .001) on days 8, 13, and 18 after culture. Maturation arrest at premeiotic SSCs was associated with a greater number and larger diameter of germ cell colonies compared with the maturation arrest at primary spermatocyte and secondary spermatocyte/spermatid stages (P < .001).
CONCLUSION: Infertile men with testicular histologic findings of maturation arrest at the premeiotic spermatogonia stage were seemingly the most appropriate candidates for testicular biopsy and in vitro propagation of human SSCs, regardless of their demographic/clinical characteristics. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21908023     DOI: 10.1016/j.urology.2011.06.035

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

Review 1.  Spermatogonial Stem Cell Culture in Oncofertility.

Authors:  Sherin David; Kyle E Orwig
Journal:  Urol Clin North Am       Date:  2020-05       Impact factor: 2.241

2.  Human Testis Extracellular Matrix Enhances Human Spermatogonial Stem Cell Survival In Vitro.

Authors:  Mark H Murdock; Sherin David; Ilea T Swinehart; Janet E Reing; Kien Tran; Kathrin Gassei; Kyle E Orwig; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2019-04       Impact factor: 3.845

Review 3.  Experimental methods to preserve male fertility and treat male factor infertility.

Authors:  Kathrin Gassei; Kyle E Orwig
Journal:  Fertil Steril       Date:  2015-12-30       Impact factor: 7.329

Review 4.  Spermatogonial Stem Cell-Based Therapies: Taking Preclinical Research to the Next Level.

Authors:  Iris Sanou; Jillis van Maaren; Jitske Eliveld; Qijing Lei; Andreas Meißner; Annemieke A de Melker; Geert Hamer; Ans M M van Pelt; Callista L Mulder
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-04       Impact factor: 6.055

Review 5.  Male fertility preservation and restoration strategies for patients undergoing gonadotoxic therapies†.

Authors:  Kien T D Tran; Hanna Valli-Pulaski; Amanda Colvin; Kyle E Orwig
Journal:  Biol Reprod       Date:  2022-08-09       Impact factor: 4.161

Review 6.  Fertility preservation for boys and adolescents facing sterilizing medical therapy.

Authors:  Ahmed A Hussein; Nam D Tran; James F Smith
Journal:  Transl Androl Urol       Date:  2014-12

7.  Upregulation of Integrin-α6 and Integrin-β1 Gene Expressions in Mouse Spermatogonial Stem Cells after Continues and Pulsed Low Intensity Ultrasound Stimulation.

Authors:  Mahdi Mohaqiq; Mansoureh Movahedin; Manijhe Mokhtari Dizaji; Zohreh Mazaheri
Journal:  Cell J       Date:  2017-11-04       Impact factor: 2.479

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.